News
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.
13h
Zacks Investment Research on MSNBristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock?Bristol Myers (BMY) delivered an impressive performance in the past month after being under pressure for quite some time. The ...
An NHS surgeon has delivered his 'hot take' on why weight-loss jabs like Wegovy and Mounjaro are causing 'Ozempic babies' to be born.
13h
Zacks Investment Research on MSNHow Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?Eli Lilly LLY offers a diverse range of products that serve multiple therapeutic areas. While the company’s primary focus is ...
Mounjaro users on Reddit are complaining of developing 'creepy' and 'saggy' skin on their necks after losing weight on GLP-1 ...
Urgent care clinics are handing out fistfuls of antibiotics, steroids and opioids for conditions these drugs won't help, a new study says.
As the stock market pushes into record territory and bargains become harder to find, investors are once again turning to some of Wall Street’s beaten down companies in hopes of a quick score. Amid ...
Stevanato has invested significant resources in expanding its operations. Click to read more on STVN's Buy rating and its ...
If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
President Trump has threatened to slap a 200% tariff on foreign-made pharmaceuticals. That would roil the $200 billion-plus market for drug imports. Here's a breakdown of which countries—and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results